Evidence map›Paper›PMID 15857981›Full record

ArticleJournal of virology2005

Mitogen-activated protein kinases regulate LSF occupancy at the human immunodeficiency virus type 1 promoter.

Loyda Ylisastigui, Rupinderjeet Kaur, Holly Johnson, Janet Volker, Guocheng He, Ulla Hansen, David Margolis

Open access · bronzeAbstract readComparative Study
In one paragraph

Article in Journal of virology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
0.8field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 23 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. YY1 and FoxD3 regulate antiretroviral zinc finger protein OTK18 promoter activation induced by HIV-1 infection.Journal of neuroimmune pharmacology : the official journal of the Society on NeuroImmune Pharmacology · 2009
    Article
  13. Article
  14. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Loyda YlisastiguiUniversity of Texas Southwestern Medical Center at Dallas, 5323 Harry Hines Blvd., Y9-206a, Dallas, TX 75390-9113, USA.
Rupinderjeet Kaur
Holly Johnson
Janet Volker
Guocheng He
Ulla Hansen
David Margolis
The University of Texas Southwestern Medical Center · USBoston University · USVA North Texas Health Care System · US

Funding

U.T. SOUTHWESTERN ADULT AIDS CLINICAL TRIALS UNITU01AI046376 · NIAID · UT SOUTHWESTERN MEDICAL CENTER · PI JAIN, MAMTA K · 2000 to 2008
$9.8M
REPRESSION OF HIV TRANSCRIPTION--A PATHWAY TO QUIESCENCER01AI045297 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI MARGOLIS, DAVID M. · 1999 to 2006
$2.5M
Clearing Persistently HIV-Infected CD4+ T LymphocytesR01AI064074 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI MARGOLIS, DAVID M. · 2005 to 2008
$2.1M
LSF AND MAMMALIAN CELL CYCLE PROGRESSIONR01CA081157 · NCI · BOSTON UNIVERSITY · PI HANSEN, ULLA M · 1999 to 2004
$1.2M
Repression of HIV Transcription: from mechanism to anti-latency therapiesR56AI045297 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI MARGOLIS, DAVID M. · 2007 to 2007
$329k
NCI NIH HHS CA81157NCI NIH HHS R01 CA081157NIAID NIH HHS AI 046376NIAID NIH HHS AI 45297NIAID NIH HHS R01 AI045297NIAID NIH HHS R01 AI064074NIAID NIH HHS R56 AI045297NIAID NIH HHS U01 AI046376
6 · The paper itself

Abstract

Human immunodeficiency virus type 1 (HIV-1) establishes a persistent, nonproductive state within a small population of memory CD4(+) cells. The transcription factor LSF binds to sequences within the HIV-1 long terminal repeat (LTR) initiation region and recruits a second factor, YY1, to the LTR. These factors then cooperatively recruit histone deacetylase 1 to the LTR, resulting in inhibition of transcription. This appears to be one mechanism contributing to HIV persistence within resting CD4(+) T cells. We sought to further detail LSF binding to the HIV-1 LTR and factors that regulate LSF occupancy. We find that LSF binds the LTR as a tetramer and that binding is regulated by phosphorylation mediated by mitogen-activated protein kinases (MAPKs). In vitro, phosphorylation of LSF by Erk decreases binding to the LTR, while binding is increased by p38 phosphorylation. LSF occupancy at LTR chromatin is increased by the p38 agonist anisomycin and decreased by specific p38 inhibition. p38 inhibition also results in increased acetylation of histone H4 at the LTR nucleosome adjacent to the LSF binding site. p38 inhibition also blocked the ability of YY1 to inhibit activation of the integrated HIV promoter. Finally, HIV was recovered from the resting CD4(+) T cells of aviremic, HIV-infected donors upon treatment of these cells with specific inhibitor of p38. These data suggest that the MAPK pathway regulates LSF binding to the LTR and thereby one aspect of the regulation of HIV expression. This mechanism could be exploited as a novel therapeutic target to disrupt latent HIV infection.

Indexed as

Cells, CulturedDNA-Binding ProteinsDown-RegulationHIV-1HIV InfectionsHIV Long Terminal RepeatHumansLeukocytes, MononuclearMitogen-Activated Protein Kinase 3Mitogen-Activated Protein Kinasesp38 Mitogen-Activated Protein KinasesPhosphorylationPromoter Regions, GeneticRNA-Binding ProteinsTranscription FactorsDNA-Binding ProteinsMitogen-Activated Protein Kinase 3Mitogen-Activated Protein Kinasesp38 Mitogen-Activated Protein KinasesRNA-Binding ProteinsTFCP2 protein, humanTranscription Factors

Identifiers

PMID15857981
PMCPMC1091734
OpenAlexW2123851487

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.